Two Sigma Securities’s Argos Therapeutics, Inc. ARGS Stock Holding History

Two Sigma Securities’s Portfolio ARGS Stock Details ARGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-27,911	Closed	-$25K	–	3230
2018 Q1	$25K	Buy	27,911 +25,513	+1,064%	+$47.8K	﹤0.01%	2559
2017 Q4	$7K	Sell	2,398 -5,102	-68%	-$17.1K	﹤0.01%	1689
2017 Q3	$27K	Buy	+7,500	New	+$36K	﹤0.01%	806

Other funds holding ARGS

Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Two Sigma Securities's ARGS Position: Q2 2018 in Review

Two Sigma Securities sold out of Argos Therapeutics, Inc. (ARGS) in Q2 2018, closing a stake of 27,911 shares — an estimated $25K sold.

Two Sigma Securities first reported a position in ARGS in Q3 2017 and held it in 3 quarters. The position peaked at $27K in Q3 2017. 4 funds tracked by Wall St. Rank hold ARGS as of Q2 2018.

Two Sigma Securities reported no remaining Argos Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
Two Sigma Securities sold 27,911 Argos Therapeutics, Inc. shares in Q2 2018, an estimated $25K.
Two Sigma Securities first reported a position in Argos Therapeutics, Inc. in Q3 2017 and held it in 3 quarters.
Two Sigma Securities's Argos Therapeutics, Inc. position peaked at $27K in Q3 2017.
4 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q2 2018.

Based on Two Sigma Securities's 13F filing for Q2 2018, filed 14 Aug 2018.